Brown & Crouppen
toll free:
800-536-4357
AVAILABLE 24/7
  • Firm Overview
    • Areas of Practice
  • Attorneys
  • Results
  • Locations
    • Saint Louis, MO Headquarters
    • Kansas City, MO Office
    • O’Fallon Law Office
    • Fairview Heights, IL Office
    • Saint Charles, MO Office
    • Arnold, MO Office
    • Washington, MO Office
  • Fees
  • Contact
IF YOU DON’T GET PAID, WE DON’T GET PAI
Home / Areas of Practice / Dangerous Drugs / Invokana and Invokamet

Invokana and Invokamet


The U.S. Food and Drug Administration (FDA) is warning that a new class of Type 2 diabetes medications, including Johnson & Johnson’s popular Invokana, can cause ketoacidosis.  Ketoacidosis is a serious condition where the body produces high levels of blood acids called ketones that may require hospitalization. The medications may also increase the risk of leg and foot amputations.

The new class of medications are called sodium-glucose co-transporter-2 (SGLT2) inhibitors. They work by causing blood sugar to leave the body through urine.

The FDA has issued warnings for the following SGLT2 medications:

  • Invokana (canagliflozin)
  • Invokamet (canagliflozin and metformin)
  • Farxiga (dapagliflozin)
  • Xigduo XR (dapagliflozin and metformin extended-release)
  • Jardiance (empagliflozin)
  • Glyxambi (empagliflozin and linagliptin)

Background

When the FDA approved Invokana in 2013, there were already concerns about the drug’s safety. Johnson & Johnson’s own experts found that, in a clinical study of patients at a high risk of heart disease, 13 suffered heart attacks or strokes within 30 days of beginning Invokana. Similar drugs had been denied approval in other countries because of the safety risks.  Despite this, the FDA approved the drug but did not require any warning about heart attacks or strokes on the label. Although the FDA did not approve the drug for weight loss, much of the advertising for Invokana has prominently featured weight loss as a benefit to taking the drug.

Dangerous side effects

The most serious potential side effects, problems and risks caused through the use Invokana and other SGLT2 inhibitors are:

  • Heart attack
  • Kidney Damage, including kidney failure 
  • Ketoacidoses
  • Leg or foot amputations

We can help

If you or someone you care about suffered one of these injuries while taking Invokana or any other SGLT2 inhibitor, contact Brown and Crouppen today for a free and confidential case evaluation.  We can help you make informed decisions about your legal rights, so please call us at Toll-Free: 800-536-4357 for your free legal consultation or save time with our online Contact Form.

800-536-4357


CLICK HERE TO
CHAT
CHAT NOW

This is Attorney Advertising. This web site is designed for general information only. The information presented at this site should not be construed to be formal legal advice nor the formation of a lawyer/client relationship.

Neither the Supreme Court of Missouri nor The Missouri Bar reviews or approves certifying organizations or specialist designations. The choice of a lawyer is an important decision and should not be based solely upon advertisements.

Past results afford no guarantee of future results. Every case is different and must be judged on its own merits. Co-counsel may be used or referral made.

Missouri’s Winningest Plaintiff Law Firm award as ranked by the editors of Missouri Lawyers Weekly in their 2011 and 2012 Missouri Lawyer Awards.

Firm News          Community Involvement          How Fees Work          Job Opportunities          Disclaimer          Contact
Awards         Legal Resources         Blog         Articles       Privacy Policy         Client Testimonials
© 2021 Brown & Crouppen, P.C. All rights reserved.
Call us Toll Free: 800-536-4357